Skip to main content
Livermore
Livermore
ZHEN

Ingalls & Snyder LLC

SEC CIK
0001041885
Latest filing
Aug 14, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Ingalls & Snyder LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
28,817
Value
$1.38M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by Ingalls & Snyder LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628,817$1.38M<0.1%−75−0.3%ReducedHolders
Q1 202628,892$1.06M<0.1%−586−2.0%ReducedHolders
Q4 202529,478$1.50M0.1%−17,246−36.9%ReducedHolders
Q3 202546,724$2.59M0.1%−3,957−7.8%ReducedHolders
Q2 202550,681$3.50M0.1%−1,130−2.2%ReducedHolders
Q1 202551,811$3.60M0.1%−835−1.6%ReducedHolders
Q4 202452,646$4.53M0.2%+961+1.9%AddedHolders
Q3 202451,685$6.15M0.2%+1,037+2.0%AddedHolders
Q2 202450,648$7.23M0.3%+19,839+64.4%AddedHolders
Q1 202430,809$3.96M0.2%−2,355−7.1%ReducedHolders
Q4 202333,164$3.43M0.2%−1,775−5.1%ReducedHolders
Q3 202334,939$3.18M0.2%00.0%UnchangedConverted for a 2-for-1 splitHolders
Q2 202317,468$2.83M0.1%00.0%UnchangedHolders
Q1 202317,468$2.78M0.1%00.0%UnchangedHolders
Q4 202217,468$2.36M0.1%00.0%UnchangedHolders
Q3 202217,468$1.74M0.1%00.0%UnchangedHolders
Q2 202217,468$1.95M0.1%00.0%UnchangedHolders
Q1 202217,468$1.94M0.1%00.0%UnchangedHolders
Q4 202117,468$1.96M0.1%00.0%UnchangedHolders
Q3 202117,468$1.68M0.1%−1,975−10.2%ReducedHolders
Q2 202119,443$1.63M0.1%−25−0.1%ReducedHolders
Q1 202119,468$1.31M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.